ARGX
NASDAQ
NL
argenx SE - American Depositary Shares
$746.42
▲ +$3.30
(+0.44%)
Vol 372K
10
Quality Score
ok
Deep Check
1/5
fail
Rev ✓
NI ✗
>IPO ✗
Mkt Cap
$44.1B
P/E
33.8
ROE
17.6%
Margin
42.5%
D/E
0.71
Beta
0.96
52W
$457–$810
Wall Street Consensus
25 analysts · Apr 20268
Strong Buy
15
Buy
2
Hold
0
Sell
0
Strong Sell
92.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $6.25 | $8.02 | +$1.77 |
| Sep 2025 | $4.37 | $5.18 | +$0.81 |
| Jun 2025 | $3.04 | $3.74 | +$0.70 |
| Mar 2025 | $2.41 | $2.58 | +$0.17 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $573.0M | $738.4M | $790.7M | $948.0M | $1.1B |
| Net Income | $91.4M | $774.2M | $169.5M | $245.4M | $344.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 17.6% | 17.6% | 17.6% | 17.6% | 17.6% | 17.6% |
| P/E (TTM) | 26.17 | 31.14 | 34.56 | 32.54 | 35.98 | 33.81 |
| Net Margin | 25.9% | -23.6% | -23.6% | -23.6% | -23.6% | 42.5% |
| Gross Margin | 88.3% | 90.8% | 90.8% | 90.8% | 90.8% | 89.6% |
| D/E Ratio | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 | 0.71 |
| Current Ratio | 5.60 | 5.60 | 5.60 | 5.60 | 5.60 | 5.60 |
Key Ratios
ROA (TTM)
15.2%
P/S (TTM)
14.38
P/B
7.7
EPS (TTM)
$23.12
Rev Growth 3Y
+63.9%
52W High
$810.00
52W Low
$456.60
$456.60
52-Week Range
$810.00
Financial Health
Net Debt
-$2.0B
Cash
$2.1B
Total Debt
$43.2M
As of Jun 30, 2025
How does ARGX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ARGX valuation vs Biotechnology peers
P/E ratio
33.8
▲
80%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
14.4
▲
12%
above
peers
(12.9)
vs Peers
vs Industry
Fair value
P/B ratio
7.7
▲
215%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ARGX profitability vs Biotechnology peers
ROE
17.6%
▲
126%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
42.5%
▲
115%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
89.6%
▲
14%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
15.2%
▲
133%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ARGX financial health vs Biotechnology peers
D/E ratio
0.7
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
5.6
▲
26%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.0
▼
1%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
ARGX fundamentals radar
ARGX
Peer median
Industry
ARGX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ARGX vs peers: key metrics
Top Holders
Top 5: 24.38%FMR, LLC
9.04%
$3.9B
Price (T.Rowe) Associates I…
5.43%
$2.3B
Janus Henderson Group PLC
3.97%
$1.7B
Capital World Investors
3.10%
$1.3B
Artisan Partners Limited Pa…
2.84%
$1.2B
As of Dec 31, 2025